Dutch researchers check if weight-loss drug lives up to hype in real-world clinics

NCT ID NCT07504172

Not yet recruiting Knowledge-focused Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will look at medical records of 1700 adults with obesity who took tirzepatide along with lifestyle coaching at several Dutch clinics. Researchers want to see how much weight people actually lose after six months and how doctors prescribe the medication in daily practice. The study does not test a new treatment—it simply observes what happens in real-world care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY (DISORDER) OVERWEIGHT , OBESITY

Contacts and locations

Locations

NOK clinics

Amsterdam, Netherlands
NOK clinics

Arnhem, Netherlands
NOK clinics

Beverwijk, Netherlands
NOK clinics

Gouda, Netherlands
NOK clinics

Heerlen, Netherlands
NOK clinics

Hoogeveen, Netherlands
NOK clinics

Nieuwegein, Netherlands
NOK clinics

Terneuzen, Netherlands
NOK clinics

The Hague, Netherlands
NOK clinics

Venlo, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.